Medpace Holdings is trading 28.53% lower at $450.41 after closing at $630.19 in the regular session on September 22, 2026, with no confirmed company-specific catalyst.

  • No confirmed company-specific announcement, earnings release, regulatory action, or analyst move explains the after-hours decline.
  • Recent coverage highlights valuation concerns ahead of upcoming earnings, but does not establish a direct catalyst for this move.